Radionuclides and healthcare: a promising future

Thursday, October 16th - Morning

Challenges in radiopharmaceutical manufacturing and metabolic radiotherapy.


Read the overview written by Richard Zimmermann

Download the presentation


Radionuclides panel discussion -Richard Zimmermann


Program and participants


Host of the panel discussion:

Richard Zimmermann, Expert Consultant in Nuclear Medicine - Chrysalium Consulting SARL



Patrick Bourdet, President & CEO of AREVA MED

Market and trends

“Current and future market in nuclear medicine”

Guy Turquet de Beauregard, CEO of IBA MOLECULAR and President of AIPES (European Industrial Association for Nuclear Medicine and Molecular Healthcare)

Technological challenges

“Radionuclides production, reactors vs cyclotron and new cameras”

Dr Kristoff Muylle, President of the Belgium Nuclear Medicine Society, Nuclear Medicine Physician at Jules Bordet Institute (Belgium)

Healthcare system (risks and opportunities)

“Nuclear medicine in the Healthcare System”

Remigiusz Barańczyk, European Commission - Euratom Supply Agency

Regulation of nuclear medicine

“Challenges and compliance in Europe for nuclear medicine”

Kevin Charlton, Senior Analyst at Nuclear Energy Agency (NEA) of the OECD

Supply and demand of medical isotopes

“Market competition and good practices”



François Sarkozy, President of FSNB Health & Care

We use cookies to enable this website to function, to make it more user friendly and to offer you products and services tailored to your interests. Please note that by using this site you are agreeing to the use of cookies.For further information about cookies and how to manage them, click here.